Navigation Links
Boston Biomedical Appoints Patricia S. Andrews as Chief Commercial Officer
Date:11/14/2013

g signs of efficacy in early-phase clinical trials in various solid tumors including colon cancer. CSC-targeted therapies such as BBI608 may offer a potentially significant clinical benefit over conventional cancer treatments."

Prior to Incyte, Ms. Andrews spent 17 years at Pfizer in positions of increasing responsibility. Her last appointment was as Vice President and General Manager of the U.S. Oncology Business Unit, a $900 million portfolio of products in colorectal cancer, breast cancer and renal cell carcinoma. Ms. Andrews received her M.B.A. from the University of Michigan and a B.A. from Brown University.

About BBI608

BBI608 is an orally-administered first-in-class anti-cancer drug created by Boston Biomedical.  It has shown the ability to inhibit the Stat3 pathways, Nanog pathways and β-catenin pathways in a pre-clinical study.  BBI608 is a small-molecule compound with a novel mechanism that blocks cancer stem cells' (cancer cells with stem cell-like properties) self-renewal and induces cell death in CSC as well as other heterogeneous cancer cells.  By targeting cancer stem cells in addition to heterogeneous cancer cells, efficacy is expected in the current challenges in therapy against cancer, such as treatment resistance, metastasis and recurrence. BBI608 is in a global Phase III clinical trial being conducted under a Special Protocol Assessment for metastatic colorectal cancer. Additional studies for BBI608 alone and in combination in colorectal cancer and other tumors are ongoing and planned.

About Boston Biomedical

Boston Biomedical, Inc. (Founder, President, CEO and CMO: Chiang J. Li, M.D. FACP) was founded in November, 2006 and is wholly owned by Dainippon Sumitomo Pharma Co., Ltd. Boston Biomedical Pharma Inc. (President: Hiroshi Nomura) was founded in October 2013 and is wholly owned by Dainippon Sumitomo Pharma America Holdings, I
'/>"/>

SOURCE Boston Biomedical
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Enterprise Associates Opens Boston Office To Serve Growing Portfolio, Pursue New Investments
2. Sensible Medical Innovations Closes on Financing Round Led by Boston Scientific Corporation
3. Shocking News & Research: Boston Scientific, Yingli Green Energy Hold, QUALCOMM, PulteGroup, Regions Financial
4. The Zacks Analyst Blog Highlights: Eaton, Baxter International, Bio-Rad Laboratories, INSYS Therapeutics and Boston Scientific
5. inMotion’s Latest Website Unveils Innovation Square, Boston’s Premier Life Science Development
6. HOLLOWAY AMERICA to Exhibit at the Boston Product Show 2013
7. FarHawk Marketing Services Represents IonBench™ and MS Noise™ at the Greater Boston Mass Spectrometry Discussion Group Corporate Night October 3rd
8. Sanofi Forms Partnership with UMass Boston with $1 Million Support of Student Success Program for STEM Education
9. UMass Boston Receives $1 Million Grant to Recruit Urban Nurse Leaders
10. Boston Scientific Completes $1.05 Billion Senior Notes Offering
11. Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  Health Enhancement Products, Inc. (OTCQB: ... early-stage algae bioactive compounds and metabolic processes, is pleased to ... board of directors. Ms. Nola E. Masterson , a ... joined the board effective September 17, 2014. ... to join our board," states Andrew Dahl , President ...
(Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... and Chinese Stem Cell Industry Report, 2014-2017" report ... undifferentiated biological cells that can differentiate into specialized cells ... cells. Stem cell therapy can be applied to treatment ... disease), nervous system diseases, damage or lesion of liver, ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Leatherwood ... FM-4910 listed material, to stay competitive in the ... These high-performance materials ultimately impact product quality and ... and owner. , Established in 1980 in Lewisville, ... as many fabricators have left the business. Much ...
(Date:9/18/2014)... Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ... announced concurrent but separate underwritten offerings of 10,000,000 shares ... public of $2.00 per share, for expected gross proceeds ... A Convertible Preferred Stock at a price to the ... of $20 million. Each share of Series A Convertible ...
Breaking Biology Technology:Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... increase its number of new technology-based companies, but ... part of their growth strategies, according to a ... technology transfer and commercialization organizations. , ,Representatives from ... Center for Advanced Technology & Innovation (CATI), and ...
... Plan , Affinity Health Systems health plan provider in ... availability of new online services for NHPs providers, members, ... management system. , ,NHP will launch the product suite ... Starting this summer, NHPs providers will be able to ...
... Louis Loeffler , technology coordinator for the Sun Prairie Area ... in education at a meeting of the World Future ... Americans than ever are getting a public education, he said, ... with the developing world. New technologies can also offer better ...
Cached Biology Technology:Three Wisconsin approaches to technology transfer and commercialization 2Three Wisconsin approaches to technology transfer and commercialization 3Three Wisconsin approaches to technology transfer and commercialization 4Three Wisconsin approaches to technology transfer and commercialization 521st century skills, the future of technology and education 221st century skills, the future of technology and education 3
(Date:9/19/2014)... biology professor will study multifunctional and specialized spinal ... a National Science Foundation grant in the amount ... Berkowitz, professor in the Department of Biology, OU ... the differences between the multifunctional and specialized spinal ... use and what connections they make. Berkowitz ...
(Date:9/19/2014)... you are a species which over thousands of years has ... to a substance that makes the cold dangerous for you. ... Enchytraeus albidus , and the cold provoking substance, called nonylphenol, ... , Nonylphenol is suspected of being a endocrine disruptor, but ... inhibits the worm,s ability to protect the cells in its ...
(Date:9/19/2014)... shows that legume plants regulate their symbiotic relationship ... are transmitted through the plant structure from leaves ... bacteria-holding nodules in the roots. This collaborative study ... for Basic Biology, the Graduate University for Advanced ... Resource Science in Japan. , Legumes, an ...
Breaking Biology News(10 mins):Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3For legume plants, a new route from shoot to root 2
... in preventing some of the stresses of open surgery on ... and organ dysfunction. Laparoscopy is a type of surgery in ... By adding another gas to the carbon dioxide used ... University Medical Center have found they can preserve more normal ...
... that are associated with the health of the human ... scientists from 63 centres in Europe and Australia sheds ... The new findings provide hope for better treatment ... and asthma. In the past it has been difficult ...
... FORT COLLINS, COWild Malus orientalis species of wild ... applesare native to the Middle East and Central Asia. ... M. orientalis varieties from Georgia and Armenia ... narrows the large population and establishes a core collection ...
Cached Biology News:Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2Understanding apples' ancestors 2
OSCP Antibody...
Ezrin/Radixin/Moesin Antibody...
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
... ( Abpromise for all tested ... Synthetic peptide based on the propeptide ... amino acid sequence is proprietary) ... SWISS Protein ID: ...
Biology Products: